Cord blood transplants supported by unrelated donor CD34+ progenitor cells

[1]  U. Gergis,et al.  Seven Years of Haplo-Cord Transplantation: Immune Reconstitution and Outcomes Using Anti-Thymocyte Globulin , 2020 .

[2]  S. Montoto,et al.  Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. , 2019, The Lancet. Haematology.

[3]  W. Stock,et al.  Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. , 2019, Blood advances.

[4]  H. Carraway,et al.  When should transplant physicians think about familial blood cancers? , 2019, Journal of Clinical Haematology.

[5]  K. van Besien,et al.  Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  M. Labopin,et al.  Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation , 2018, American journal of hematology.

[7]  I. Buño,et al.  Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia. , 2017, Blood advances.

[8]  K. Besien,et al.  Against the odds: haplo-cord grafts protect from GvHD and relapse , 2017, Bone Marrow Transplantation.

[9]  M. Perales,et al.  Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  J. Wagner,et al.  Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  H. Rennert,et al.  Haplo-cord transplant: HLA-matching determines graft dominance , 2017, Leukemia & lymphoma.

[12]  J. Kurtzberg,et al.  Excellent Outcomes in 1589 Patients Receiving Umbilical Cord Blood Transplantation Using Unlicensed Units From a Centralized Cord Blood Registry , 2017 .

[13]  J. Sierra,et al.  Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  H. Rennert,et al.  Cord blood chimerism and relapse after haplo-cord transplantation , 2017, Leukemia & lymphoma.

[15]  F. Appelbaum,et al.  Cord-Blood Transplantation in Patients with Minimal Residual Disease. , 2016, The New England journal of medicine.

[16]  D. Pollyea,et al.  Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation , 2016, Bone Marrow Transplantation.

[17]  R. Larson,et al.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  R. Larson,et al.  Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival , 2016, Haematologica.

[19]  B. Wood,et al.  Cord-Blood Transplantation in Patients with Minimal Residual Disease. , 2016, The New England journal of medicine.

[20]  J. Sierra,et al.  Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia , 2015, Leukemia.

[21]  M. MacMillan,et al.  Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. , 2015, Blood.

[22]  S. Devine,et al.  Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia , 2015, British journal of haematology.

[23]  I. Buño,et al.  Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  I. Buño,et al.  Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells , 2014, Bone Marrow Transplantation.

[25]  A. Zachary,et al.  Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  R. Larson,et al.  Immune reconstitution after combined haploidentical and umbilical cord blood transplant , 2013, Leukemia & lymphoma.

[27]  J. Goldberg,et al.  A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  R. Larson,et al.  Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. , 2011, Blood.

[29]  J. Wingard,et al.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. , 2011, Blood.

[30]  I. Millán,et al.  Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor , 2009, Bone Marrow Transplantation.

[31]  E. Shpall,et al.  Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. , 2007, Blood.

[32]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .